The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer.

Background And Purpose: Short course radiotherapy (SCRT) has a low biological prescription dose. Rectal cancer has a dose response relationship and moderate α/β ratio (∼5). We hypothesise hypofractionated dose escalation has radiobiological advantages.